- $1.79bn
- $2.72bn
- $5.97bn
- 92
- 91
- 33
- 84
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 6.5 | ||
| PEG Ratio (f) | 0.55 | ||
| EPS Growth (f) | 13.44% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.58 | ||
| Price to Tang. Book | 8.83 | ||
| Price to Free Cashflow | 14.02 | ||
| Price to Sales | 0.3 | ||
| EV to EBITDA | 4.95 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 10.03% | ||
| Return on Equity | 23.34% | ||
| Operating Margin | 6.74% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | 4,870.4 | 5,129.69 | 5,409.48 | 5,966.07 | 6,327.68 | 6,680.42 | 7% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | -7.22 | +16.27 | +384.62 | +17.9 | +5.34 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Ardent Health Partners, Inc., formerly Ardent Health Partners, LLC, is a provider of healthcare services in the United States. The Company operates in eight mid-sized urban markets across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. It provides both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. In addition to its 30 acute care hospitals, it operates a broad network of ambulatory facilities and telehealth services, including 146 primary care and specialty care clinics, three ambulatory surgery centers (ASCs), 40 urgent care centers, two freestanding emergency departments, and ten diagnostic imaging centers. The Company also operates a consumer-centric healthcare platform focused on creating long-lasting relationships with its patients across multiple care settings.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- June 29th, 2015
- Public Since
- July 18th, 2024
- No. of Shareholders
- 210
- No. of Employees
- 19,200
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
New York Stock Exchange- Shares in Issue
- 142,750,013
- Address
- 340 SEVEN SPRINGS WAY, SUITE 100, BRENTWOOD, 37215
- Web
- https://ardenthealth.com/
- Phone
- +1 6152963000
- Auditors
- Ernst & Young LLP
Upcoming Events for ARDT
Q1 2025 Ardent Health Partners Inc Earnings Release
Q1 2025 Ardent Health Partners Inc Earnings Call
Q1 2025 Ardent Health Partners Inc Earnings Call
Ardent Health Partners Inc Annual Shareholders Meeting
Ardent Health Partners Inc Annual Shareholders Meeting
Similar to ARDT
Agilon Health
New York Stock Exchange
AMERICAN WELL
New York Stock Exchange
AMN Healthcare Services
New York Stock Exchange
Auna SA
New York Stock Exchange
Brookdale Senior Living
New York Stock Exchange
FAQ
What is the Ardent Health Partners share price?
As of Today at 19:20 UTC, shares in Ardent Health Partners are trading at $12.52. This share price information is delayed by 15 minutes.
How has the Ardent Health Partners share price performed this year?
Shares in Ardent Health Partners last closed at $12.52 and the price had moved by over the past 365 days. In terms of relative price strength the Ardent Health Partners share price has matched the S&P500 Index by over the past year.
What are the analyst and broker recommendations for Ardent Health Partners?
The overall consensus recommendation for Ardent Health Partners is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Ardent Health Partners dividend yield?
Ardent Health Partners does not currently pay a dividend.
Does Ardent Health Partners pay a dividend?
Ardent Health Partners does not currently pay a dividend.
When does Ardent Health Partners next pay dividends?
Ardent Health Partners does not currently pay a dividend.
How do I buy Ardent Health Partners shares?
To buy shares in Ardent Health Partners you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Ardent Health Partners?
As of the previous close price of $12.52, shares in Ardent Health Partners had a market capitalisation of $1.79bn.
Where are Ardent Health Partners shares listed?
Here are the trading details for Ardent Health Partners:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: ARDT
What kind of share is Ardent Health Partners?
Based on an overall assessment of its quality, value and momentum Ardent Health Partners is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Ardent Health Partners share price forecast for 2025?
The analyst consensus target price for shares in Ardent Health Partners is $20.11. That is 60.62% above the last closing price of $12.52.
Analysts covering Ardent Health Partners currently have a consensus Earnings Per Share (EPS) forecast of $1.89 for the next financial year.
Find out moreWhat is the trend in the Ardent Health Partners share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Ardent Health Partners. Over the past six months, its share price has underperformed the S&P500 Index by -25.61%.
As of the last closing price of $12.52, shares in Ardent Health Partners were trading -22.29% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Ardent Health Partners PE Ratio?
The Ardent Health Partners PE ratio based on its reported earnings over the past 12 months is 6.5. The shares last closed at $12.52.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Ardent Health Partners?
We do not have data on Ardent Health Partners' directors